Stock listing
Entropy Neurodynamics Limited
Selected listing: TYPTF · OTC · USD · US
Entropy Neurodynamics Limited (OTC:TYPTF), Health Technology. Latest release Sep 13, 2026: All Patients Improve, 50% Achieve 12-Week BED Remission.
- Ticker
- OTC:TYPTF
- Asset type
- Stock
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- Exchange
- OTC
- Currency
- USD
About Entropy Neurodynamics Limited
The company focuses on developing innovative solutions in the field of neurodynamics. Its commitment to advancing technology in this sector positions it as a notable player in the industry.
Latest news from Entropy Neurodynamics Limited
All Patients Improve, 50% Achieve 12-Week BED Remission
September 13, 2026
Appendix 4E and 2026 Annual Report
August 27, 2026
Entropy Advances TRP-8803 to US Phase 2 in Depression
August 25, 2026
TRP 8803 manufacturing secured for Phase 2/3 advancement
August 18, 2026
72 patient multi-indication trial approved to fast track TRP-8803 commercialisation
August 4, 2026
Research Entropy Neurodynamics Limited
Entropy Neurodynamics Limited company profile
View the public company page for Entropy Neurodynamics Limited on 6ix.
Entropy Neurodynamics Limited news
Read company news and market updates connected to Entropy Neurodynamics Limited.
Entropy Neurodynamics Limited investor events
Find investor webinars, events, and replay context for Entropy Neurodynamics Limited.